XML 20 R2.htm IDEA: XBRL DOCUMENT v2.4.0.6
CONSOLIDATED BALANCE SHEETS (USD $)
Dec. 31, 2012
Jun. 30, 2012
CURRENT ASSETS:    
Cash and cash equivalents $ 23,548 $ 9,389
Short term bank deposits 32,143 21,397
Marketable securities 8,882 7,023
Other accounts receivable and prepaid expenses 1,699 383
Total current assets 66,272 38,192
LONG-TERM ASSETS:    
Long-term deposits and restricted deposits 756 1,287
Advance payment for leasehold improvements 1,305 2,400
Property and equipment, net 10,026 5,019
Severance pay fund 702 522
Other long term assets 59   
Total long-term assets 12,848 9,228
Total assets 79,120 47,420
CURRENT LIABILITIES    
Trade payables 3,397 1,368
Accrued expenses 426 922
Deferred revenues 779 779
Advance payment from United Therapeutics 599 1,576
Other accounts payable 925 877
Total current liabilities 6,126 5,522
LONG-TERM LIABILITIES    
Deferred revenues 3,116 3,505
Accrued severance pay 834 651
Total long-term liabilities 3,950 4,156
COMMITMENTS AND CONTINGENCIES      
STOCKHOLDERS' EQUITY    
Common stock $0.00001 par value: Authorized: 100,000,000 shares Issued and outstanding: 58,331,956 shares as of December 31, 2012, 46,448,051 shares as of June 30, 2012      
Additional paid-in capital 142,912 103,619
Accumulated deficit (74,232) (65,747)
Other comprehensive gain (loss) 364 (130)
Total stockholders' equity 69,044 37,742
Total liabilities and stockholders' equity $ 79,120 $ 47,420